SCHEMBL3170960

SCHEMBL3170960

CC(=O)NCCNc1cc(NCCNC(=O)C=Cc2ccc(C(C)C)cc2)nc(-c2ccccc2)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.53
PKM P14618 2/20 0.53
HTT P42858 1/20 0.53
ALDH1A1 P00352 6/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
PIM2 Q9P1W9 1/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
EGFR P00533 2/20 0.44
MAPT P10636 2/20 0.43
ALOX12 P18054 1/20 0.43
ADORA2A P29274 1/20 0.41
ADORA1 P30542 1/20 0.41
KMT2A Q03164 2/20 0.41
ESR1 P03372 2/20 0.41
ESR2 Q92731 2/20 0.41
POLB P06746 2/20 0.41
KDM4E B2RXH2 2/20 0.40
NLRP3 Q96P20 1/20 0.40
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3170956 1.00 LMNA (0.53) LMNAPKMHTTALDH1A1SMN1; SMN2
SCHEMBL3163351 0.91 SMN1; SMN2 (0.51) LMNAPKMHTTALDH1A1SMN1; SMN2
SCHEMBL3163340 0.91 SMN1; SMN2 (0.51) LMNAPKMHTTALDH1A1SMN1; SMN2
SCHEMBL3171072 0.91 PIM2 (0.54) ALDH1A1SMN1; SMN2PIM2NPC1RAB9A
SCHEMBL3171042 0.91 PIM2 (0.54) ALDH1A1SMN1; SMN2PIM2NPC1RAB9A
SCHEMBL3161484 0.88 LMNA (0.53) LMNAPKMHTTALDH1A1SMN1; SMN2
SCHEMBL3161481 0.88 LMNA (0.53) LMNAPKMHTTALDH1A1SMN1; SMN2
SCHEMBL3170642 0.86 KMT2A (0.49) LMNAALDH1A1SMN1; SMN2PIM2NPC1
SCHEMBL3170630 0.86 KMT2A (0.49) LMNAALDH1A1SMN1; SMN2PIM2NPC1
SCHEMBL3160896 0.84 PIM2 (0.49) LMNAALDH1A1PIM2MAPTADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed